Healthcare Services

Gastric Volvulus Treatment Market Future Analysis Covering Industry Shifts And Growth Potential

May 28, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Gastric Volvulus Treatment Market’s Market Value Anticipated To Evolve From 2026 To 2030?

The gastric volvulus treatment market has seen significant expansion in recent years. This market is set to increase from $28.86 billion in 2025 to $30.8 billion in 2026, registering a compound annual growth rate (CAGR) of 6.7%. The observed growth in past periods can be credited to the accessibility of surgical treatment options, the rise of hospital emergency care, enhanced diagnosis through imaging tests, the evolution of gastropexy procedures, and progress in surgical expertise.

The gastric volvulus treatment market size is projected to experience substantial growth in the upcoming years. It is anticipated to expand to $39.4 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.3%. This expansion during the forecast period is primarily driven by the increasing prevalence of minimally invasive surgery, improvements in emergency response systems, wider adoption of advanced imaging technologies, the proliferation of specialty surgical centers, and a rise in clinical awareness. Prominent trends for the forecast period include a growing preference for surgical intervention, enhanced adoption of minimally invasive procedures, better emergency diagnosis and management, the expansion of specialized surgical care, and a strong focus on rapid treatment to decrease mortality.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9382&type=smp

What Key Growth Drivers Are Influencing The Gastric Volvulus Treatment Market?

The expansion of the gastric volvulus treatment market is anticipated to be driven by an increasing elderly demographic. This demographic encompasses individuals aged 65 years and older. Older individuals frequently experience diverse health conditions attributable to diminished immunity and advancing age. Gastric volvulus specifically affects older adults over the age of 50. Consequently, an increase in the geriatric population is projected to fuel market progression. Illustratively, data from January 2024, released by the Population Reference Bureau (PRB), a US-based nonprofit organization, forecasts a rise in the count of Americans 65 and older from 58 million in 2022 to 82 million in 2050 (a 47% increase), with their share of the total population expanding from 17% to 23%. This demonstrates that increasing geriatric populations are propelling the gastric volvulus treatment market.

How Does Segment Analysis Break Down The Gastric Volvulus Treatment Market Structure?

The gastric volvulus treatment market covered in this report is segmented –

1) By Type: Organo-Axial Volvulus, Mesentero-Axial Volvulus

2) By Treatment Type: Medication, Surgery

3) By Route Of Administration: Oral, Parenteral

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy

5) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:

1) By Organo-Axial Volvulus: Surgical Intervention, Endoscopic Management, Gastropexy

2) By Mesentero-Axial Volvulus: Surgical Intervention, Gastropexy, Endoscopic Techniques

What Trends Are Driving Changes In The Gastric Volvulus Treatment Market?

Leading companies within the gastric volvulus treatment market are concentrating on creating innovative treatments, including advanced oral immunomodulatory therapies, to satisfy the growing need for sophisticated options that enhance prolonged disease management and patient well-being. Such orally delivered treatments specifically address inflammatory and immune-related processes, providing a more convenient and focused choice over conventional systemic therapies, which often involve greater risks of side effects and demand more rigorous oversight. As an illustration, in October 2023, Pfizer Inc., a US-based pharmaceutical firm, disclosed the U.S. Food and Drug Administration (FDA) approval of VELSIPITY (etrasimod). VELSIPITY (etrasimod) functions as a once-daily oral sphingosine-1-phosphate (S1P) receptor activator, intended for individuals suffering from moderate to severe active ulcerative colitis (UC). The recommended official dosage for VELSIPITY is 2 mg. This medication enables adults experiencing moderately to severely active UC to attain steroid-free remission through a daily oral tablet possessing a favorable benefit-risk assessment. The recent FDA endorsement of VELSIPITY represents a significant milestone for UC patients who need new treatments for their chronic condition and are prepared to commence advanced therapeutic interventions.

Which Companies Are Influencing The Gastric Volvulus Treatment Market?

Major companies operating in the gastric volvulus treatment market are Medtronic plc, Johnson & Johnson Services Inc., Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Karl Storz SE & Co KG, Cook Group Incorporated, B Braun Melsungen AG, ConMed Corporation, Fujifilm Holdings Corporation, Pentax Medical (Hoya Corporation), Ambu A S, Richard Wolf GmbH, USGI Medical, Ovesco Endoscopy AG, Endo Tools Therapeutics SA, ErgoSuture, Sutrue Ltd, Golden Stapler Surgical Co Ltd, TransEnterix Inc.

Access The Complete Gastric Volvulus Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report

Which Region Has The Strongest Presence In The Gastric Volvulus Treatment Market?

North America was the largest region in the gastric volvulus market in 2025. Asia-Pacific is expected to be the fastest-growing region in the gastric volvulus treatment market report during the forecast period. The regions covered in the gastric volvulus treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Gastric Volvulus Treatment Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=9382&type=smp

Browse Through More Reports Similar to the Global Gastric Volvulus Treatment Market 2026, By The Business Research Company

Peptic Ulcer Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/peptic-ulcer-global-market-report

Pressure Ulcers Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/pressure-ulcers-treatment-global-market-report

Duodenal Ulcer Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/duodenal-ulcer-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795